POST FINASTERIDE SYNDROME ( PSF)
and the FOOD and DRUG ADMINISTRATION (FDA)
Use of 5 alpha-reductase
inhibitors after the Food and Drug
Administration (FDA)
See
powerpoint:
Between 1993 and 2020,
the iatrogeny
has reproduced and aggravated two pathologies
through the manufacture of
5-alpha-reductase for illusory and dangerous
prescriptions :
The syndrome of prostate atrophy
(1979)
and
The androgenic disease of andropause (1988)